Oxford Global’s Q&A session with Drug Discovery USA speaker Matthew Wagoner, a discovery safety specialist from AstraZeneca
31 July 2015 | By Oxford Global
In the run up to our 2nd Annual Drug Discovery USA Congress 2015, we spoke with Matthew Wagoner a discovery safety specialist from AstraZeneca, a confirmed speaker at the congress where he will talk about Bromodomain And ExtraTerminal (BET) Domain Inhibitors Induce A Loss Of Intestinal Stem Cells And Villous…